Initiating Coverage |
2 April
2018
Sector: Chemicals
Tata Chemicals
Flight of rebirth
Sumant Kumar - Research Analyst
(Sumant.Kumar@motilaloswal.com);+9122 6129 1569
Research Analyst: Chintan Modi
(Chintan.Modi@motilaloswal.com); 3982 5422/Aksh
Vashishth
(Aksh.Vashishth@motilaloswal.com)
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.

Tata Chemicals
Contents: Tata Chemicals - Flight of rebirth
Flight of rebirth .................................................................................................... 3
Company overview ............................................................................................... 5
Transforming to a consumer product focused company ......................................... 8
Directing cash inflow toward efficient businesses .................................................. 9
Unleashing the specialty & consumer business potential ..................................... 12
Expanding horizons of speciality – nutraceuticals to enable flight ........................ 19
HDS – a future technology for tyre industry......................................................... 23
Soda ash to show steady performance ................................................................ 25
Farm inputs continue to aid growth .................................................................... 38
SWOT Analysis ................................................................................................... 39
Bull & Bear case
................................................................................................. 40
Transition into a net debt-free entity by FY20 ..................................................... 41
Valuation and view............................................................................................. 44
Key risks ............................................................................................................. 47
Management overview....................................................................................... 48
Financials and valuations .................................................................................... 49
In what is a myth, the eagle can live up to 70 years, but to
reach this age, it must make a hard decision in its 40's. By
the time it reaches the age of 40, its talons can no longer
grab prey and its beak becomes bent. Its old, heavy wings
make it difficult to fly. It is left with only two options: die
or go through a painful process of change. The process
requires that the eagle fly to a mountain top and sit in its
nest. There, it knocks its beak against a rock till it falls off.
Then it waits for a new beak to grow, following which it
plucks out its talons. When its talons grow back, the eagle
starts plucking its old-aged feathers. After five months, the
eagle takes its legendary
flight of rebirth
and lives for 30
more years.
2 April 2018
2

Tata
Initiating Coverage | Sector: Chemicals
Tata Chemicals
BSE Sensex
33,255
S&P CNX
10,212
CMP: INR692
TP: INR940 (+36% )
Buy
Tata Chemicals (TTCH) is a 78-year-old commodities company, reinventing itself as a
specialty and consumer products company. It has a diversified portfolio of businesses:
Stock Info
Bloomberg
Equity Shares (m)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
M.Cap. (INR b)
M.Cap. (USD b)
Avg Val, INRm
Free float (%)
(a) soda ash and sodium bicarbonate, where it enjoys global leadership, (b) fertilizers,
TTCH IN
254.8
781 / 558
1/3/3
176.1
2.7
565.0
69.2
which it is exiting from, (c) agricultural inputs, through subsidiary, Rallis India, (d)
consumer products such as branded iodized salt, pulses and spices, and (e) a fledging
specialty products business – materials such as highly dispersible silica (HDS) and
nanomaterial, and nutritional products like oligosaccharides and polyols. It also has
sizable financial investments that it can liquidate to fund its growth.
Financial Snapshot (INR b)
Y/E Mar
FY18E FY19E FY20E
Net Sales
105.8 115.5 126.3
EBITDA
22.6 24.7 27.2
PAT
8.6 11.2 12.8
EPS (INR)
33.7 44.0 50.3
Gr. (%)
0.0 30.5 14.3
BV/Sh (INR)
368.7 394.1 423.2
RoE (%)
11.3 11.5 12.3
RoCE (%)
7.8
9.1
9.9
P/E (x)
20.5 15.7 13.8
P/BV (x)
1.9
1.8
1.6
Shareholding pattern (%)
As On
Dec-17 Sep-17
Promoter
30.8
30.8
DII
31.5
27.9
FII
11.5
15.1
Others
26.2
26.1
FII Includes depository receipts
Flight of rebirth
Transforming into a growth company; re-rating imminent
Dec-16
30.8
29.7
18.6
21.0
TTCH is using its cash cows – soda ash and sodium bicarbonate – to build growth
businesses such as consumer and specialty products. In the consumer business, it
enjoys leadership in the domestic table salts market and is fortifying its pulses and
spices portfolios. In the specialty products business, it is developing nanomaterial
and nutritional solutions.
Massive cash generation of INR39.7b via divestment of the urea and phosphatic
fertilizers business and sale of investments coupled with steady accruals from the
soda ash business would help TTCH repay debt. Its interest outgo is likely to
decline from INR4.1b in FY17 to INR2.1b in FY20.
As TTCH scales up its growth businesses and deleverages its balance sheet, we
expect its consolidated RoCE to improve considerably, in turn driving a stock re-
rating. We believe it would be fair to assign ~30% premium to its five-year
average EV/EBITDA of 7.5x. Our SOTP-based target price of INR940 (implied
EV/EBITDA of 9.7x FY20E) implies 36% upside. We initiate coverage with Buy.
Using cash cows to invest in growth businesses
TTCH is the global leader in soda ash and sodium bicarbonate. These are
mature, commodity businesses, growing at 3-4% per year and yielding
consistent cash flows. TTCH is using these cash cows to build growth businesses
such as consumer and specialty products. The company should be able to
enhance focus on these businesses following its exit from the regulated fertilizer
business. We expect the contribution of specialty and consumer products to
increase from 27% in FY17 to 33% by FY20, based on the progress in its existing
portfolio, though the company’s internal target is to reach 50% via the launch of
new products. TTCH enjoys leadership in the domestic table salts market and
will continue focusing on growing its other specialty and consumer products,
including nutraceuticals and silica. We expect specialty and consumer products
revenue to grow at a CAGR of ~14%, outpacing the overall growth of 9% over
FY18-20.
Tata Chemicals
Flight of rebirth
Sumant Kumar
+
91 22 3078 4702
Sumant.Kumar@motilaloswal.com
Please click here for Video Link
2 April 2018
3

Tata Chemicals
Stock Performance (1-year)
To be net debt-free by FY20; RoCE to improve considerably
Divestment of the fertilizer business and sale of Tata Global Beverages shares should
result in cumulative gross cash inflow of ~INR39.7b in FY18. Internal accruals would
add further to cash flows. TTCH is also focusing on working capital, which has
reduced by INR21b in two years. Strong cash flows will allow part repayment of debt
and also help invest in higher-RoCE businesses like specialty and consumer products.
TTCH is investing in manufacturing facilities for new materials (such as HDS and
nanomaterial) and nutritional solutions (such as oligosaccharides and polyol). At full
potential, these businesses should generate RoCE of 20-25%. We expect the
company to be net debt free by FY20 from net-debt-to-equity of 0.7x in FY17.
Interest outgo should reduce from INR4.1b in FY17 to INR2.1b in FY20, enabling 22%
CAGR in continuing business profitability over FY18-20.
Focus now on consumer…
TTCH has been a pioneer in developing the market for iodized salt in India, and
enjoys a share of 25% in the country’s powdered salt market. It has a distribution
network of 1.7m retail outlets, reaching 143m households across India. Compared to
the other prominent FMCG companies in India that have an average retail reach of
5m-6m outlets, we believe TTCH has ample headroom available for growth.
Leveraging on the network, TTCH has expanded its horizons to include branded
pulses, spices, besan (pulse flour) and water purifiers, where it is yet to realize full
potential.
…and specialty products
TTCH is also entering nutritional solutions. We believe nutraceuticals presents a
huge global opportunity, with an estimated B2B market size of ~USD60b in 2016 and
B2C market size of ~USD182b, which is expected to grow at 9% CAGR till 2021. At
full utilization, we expect the current planned nutraceuticals capacity addition (likely
to be commercialized by 1QFY20) to contribute 4% of consolidated sales and 5% of
consolidated EBITDA. This would increase to 9% of consolidated sales and 10% of
consolidated EBITDA on doubling capacity, and 13% of consolidated sales and 15%
of consolidated EBITDA on tripling capacity, with global B2B market share at just 0.1-
0.3%. Besides, it is foraying into yet another technology-enabled, differentiated
business – highly dispersible silica (HDS). HDS is a substitute for carbon black, which
had a market of INR50b in India in 2016.
Initiating coverage with a Buy rating
TTCH has traded at a one-year forward EV/EBITDA of 7.5x (average) for the last five
years. Our SOTP-based target price is INR940 (implied EV/EBITDA of 9.7x).
Considering the increased focus/business transformation toward higher-RoCE
segments (specialty and consumer products) and the divestment of a regulated
business (fertilizers), we believe it is fair to assign ~30% premium to its five-year
average EV/EBITDA. We expect TTCH to continue its journey to become a larger
specialty and consumer play. As at the end of FY17, net debt stood at INR52b. We
expect the company to become net-debt-free by FY20, with (i) cash generated from
the divestment of the fertilizer business, (ii) sale of investment in Tata Global
Beverages shares, (iii) internal accruals, and (iv) potential sale of investment in
group companies. Average free cash flow yield over FY19-20 is estimated at ~9%.
We initiate coverage with a
Buy
rating and a target price of INR940 –36% upside.
2 April 2018
4

Tata Chemicals
Company overview
Tata Chemicals (TTCH) started its journey in 1939 from Mithapur, Gujarat. It is
now a global company with businesses in inorganic chemicals & crop nutrition,
crop protection and consumer products.
The company is the world’s second largest soda ash producer with combined
capacity of ~4.2m tons. With manufacturing facilities in India, UK, Kenya and US,
TTCH is the world’s most geographically diversified soda ash firm, with almost
two thirds of capacity comprising natural soda ash.
Geographical Revenue
Europe,
12%
Exhibit 1: TTCH’s segmental and geographical mix (FY17)
Segmental Revenue
Segmental EBITDA
Speciality
&
consumer
, 27%
Speciality
&
consumer
, 29%
Africa,
4%
Fertilizer,
16%
Commodi
ty, 56%
Fertilizer,
3%
Commodi
ty, 68%
America,
24%
Asia,
60%
Note: Specialty consumer includes salt, other consumer and agri inputs, Source: Company, MOSL
Exhibit 2: TTCH’s sales mix
FY15
FY17
16%
43%
36%
12%
56%
9%
15%
67%
18%
FY20E
14%
13%
Exhibit 3: TTCH’s EBITDA mix
FY15
10%
18%
57%
15%
68%
13%
67%
15%
FY17
3%
FY20E
19%
16%
Source: Company, MOSL
2 April 2018
5

Tata Chemicals
Exhibit 4: TTCH’s EBITDA margin mix
Fertiliser
25%
22%
15%
17%
13%
19%
Consumer
Agri inputs
Soda Ash & other inorganic chemical
27%
20%
16%
4%
3%
FY15
FY17
0%
FY20E
Source: Company, MOSL
Exhibit 5: TTCH’s business segments
Living Essentials
•TTCH aims to provide nourishment and nutrition to millions of consumers across
India through iodized and iron-fortified salt, high protein unpolished pulses, aromatic
spices, as well as nutritional products and ingredients -- Nx (low-calorie sugar
substitute) and NQ range.
•Tata Swach is an innovative, low-cost, nanotechnology-based, offline water purifier,
providing safe water to the masses through a social enterprise model
.
Industry Essentials
•TTCH strives to provide sustainable inorganic chemistry solutions to customers across the
globe. The key products, soda ash and sodium bicarbonate are vital ingredients to diverse
industries including glass, detergents, sodium silicate, textiles, food, feed, mining and
chemical processing.
•The company's business strategy is delivering value-added, differentiated products and
solutions while driving cost competitiveness.
Farm Essentials
•TTCH offers multiple farm inputs that are required to improve crop health and productivity.
These include fertilizers, pesticides, specialty nutrients, seeds and agro-services.
•Tata Kisan Sansar and Rallis Kisan Kutumb are networks that offer information on new and
improved agronomic practices and facilitate use of agricultural inputs.
Source: Company, MOSL
2 April 2018
6

Tata Chemicals
Exhibit 6: TTCH’s inorganic business segment
TTCH - Inorganic
Chemicals
Soda Ash
Mithapur,
Gujarat, India
TCNA - North
America
Green River,
Wyoming, USA
TCEHL -
Europe
Northwhich,
UK
Sodium Bi
Carbonate
TCAHL - Africa
Mithapur,
Gujarat, India
TCEHL - Europe
Salt
Mithapur,
Gujarat, India
Magadi, Lake
Magadi, Kenya
Northwhich, UK
Source: Company, MOSL
Exhibit 7: TTCH’s global presence
Source: Company, MOSL
2 April 2018
7

Tata Chemicals
Transforming to a consumer product focused company
Specialty and consumer products to contribute 33% of revenue by FY20
Under its commodity portfolio, TTCH operates the soda ash and sodium bicarbonate
business, wherein it is a global leader. This business acts as a cash generator (steady in
terms of growth: average of 3-4%).
It also has growth engines in the form of the specialty and consumer products – the
company should be able to enhance focus on this business following its exit from the
regulated fertilizer business.
We expect the contribution of the specialty and consumer business to increase from
25% in FY18 to 33% by FY20 (based on its existing portfolio), while the company's
internal target is to reach 50% via the launch of new products.
Specialty and consumer (S&C) to contribute 33% to total revenue by FY20
The commodity business (73% of revenue) as of FY17 includes soda ash, sodium bi-
carbonate, cement and fertilizers. The S&C business (27% of revenue in FY17)
includes salt, agri inputs, pulses, spices and nutritional solutions. As planned, TTCH
has exited the highly regulated fertilizer business (urea and phosphatic), allowing it
to focus more of the efficient S&C business – the contribution of this business is
expected to increase to 33% by FY20, considering the current product portfolio.
However, the company aims to take the total contribution of the business to 50%
based on its planned product pipeline. EBITDA of the S&C business is expected to
grow at a CAGR of 14.6% over FY18-20 to INR8.8b while EBITDA of the commodity
business is likely to grow at a CAGR of 6.4% to INR17.8b.
Exhibit 8: Contribution of specialty & consumer business to increase to 33% in FY20
Specialty and Consumer Business
Commodity Business
76%
73%
75%
69%
67%
24%
FY16
27%
FY17
25%
FY18E
31%
FY19E
33%
FY20E
Source: Company, MOSL
Exhibit 9: S&C business revenue to grow at ~14.2% CAGR
over FY18-20E
Specialty and Consumer Business Revenue (INR b)
Growth (%)
14.1
14.2
Exhibit 10: Commodity business to decline at CAGR of 5.5%
over FY18-20E
Commodity Business Revenue (INR b)
Growth (%)
7.0
-1.3
36.6
98.4
-11.9
36.6
FY16
FY17
32.2
FY18E
36.8
FY19E
42.0
FY20E
118.3
FY16
FY17
-16.9
97.1
FY18E
-16.6
81.0
FY19E
86.7
FY20E
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
8

Tata Chemicals
Directing cash inflow toward efficient businesses
Selling of stake in group companies and exit from regulated fertilizer
business to help generate cash flows
The divestment of the fertilizer business and the sale of investment in Tata Global
Beverages are expected to result in cumulative gross cash inflow of ~INR39.7b in FY18.
Internal accruals should also further aid cash flow.
The company is also focusing on working capital, which has reduced by INR21b over
the past two years. Strong cash flows will allow part repayment of debt and also help
to invest in higher-RoCE businesses like specialty & consumer.
We expect TTCH to be net debt free by FY20 from net-debt-to-equity of 0.7x in FY17.
This will also help reduce interest outgo from INR4.1b in FY17 to INR2.1b in FY20,
boosting profitability.
Part cash flow will also be invested in manufacturing facilities to develop scale in the
specialty business of new materials (such as HDS and nanomaterial) and nutritional
solutions (such as oligosaccharides and polyol). At full potential, these businesses
should generate RoCE of 20-25%.
Reduction in debt via sale of fertilizer business and investments
TTCH sold its urea and customized fertilizer business in Babrala to Yara Fertilizers
India in August 2016 for INR26.8b. The transfer of assets to Yara was completed on
12 January 2018. It also sold its phosphatic fertilizer business in November 2017 for
INR3.75b excluding outstanding subsidy amounts. The transaction is expected to be
completed by March 2018.The move was driven by TTCH’s plan to build the
consumer and inorganic chemical businesses, and to focus on the farm business
through subsidiaries, Rallis and Metahelix. This should help TTCH to focus more on
the commodity and specialty & consumer businesses, and thus, foster growth.
TTCH was also able to reduce its working capital by selling the urea business – note
that the fertilizer business is government-regulated and requires significant
investments. Sale of the urea segment proved beneficial for TTCH as working capital
in this business accounted for 31% of the company’s overall working capital.
TTCH has reduced debt through focus on working capital, ultimately leading to a
reduction in the debt-to-equity ratio to 0.7x in FY17 from 1.1x in FY16.
Exhibit 11: Urea business WC investment constitutes 31% of total investment in WC
Particulars
Inventories
Trade Receivable
Less: Trade Payable
Net
TTCH INR m
15,075.4
29,227.7
13,468.5
30,834.6
For Urea Business
1,266.8
8,344.2
89.1
9,521.9
Urea Business as a %
of Total TTCH
8%
29%
1%
31%
Source: Company, MOSL
2 April 2018
9

Tata Chemicals
Exhibit 12: Cash flow from sale from fertilizer business and investments
Particulars
Urea business
Deal Value (1)
Book Value (2)
Subsidy as a part of deal (3)
Capital appreciation (1-2-3)
Tax @30% on capital appreciation
Profit/Net Cash from sale of Urea (Excluding Subsidy) (A)
Net Cash from sales of Urea (Including Subsidy) (G)
Tata Global Beverage
Sales of TGBL shares (43.18 mn share @ 213.35) (H)
BV of TGBL
Profit from sale (B)
Phosphatic Fertilisers business
Deal Value (D)
Book Value of Business (E)
Loss from sale of phosphatic fertiliser (D-E) (F)
Complex fertiliser subsidy outstanding as on Q3FY18 (I)
Total Cash inflow (Including loss from sale from phosphatic fertilizer and urea subsidy
(G+H+D+F+I)
Profit from Sale of Urea & phosphatic fertiliser and TGBL (A+B+F)
INR m
26,820
10,210
7,400
9,210
2,763
16,657
24,057
9,211
6,500
2,711
3,750
8,863
-5,113
7,840
39,745
14,255
Source: Company, MOSL
Stake sale in Tata Global Beverages generated cash of INR9.2b
The Tata Group has been in constant talks to reduce the complexity in group
holdings, which would help group companies to carry core assets on its balance
sheets, and thus, allocate capital efficiently. Cross-holdings in companies where
shares of different companies are held by each other are being reduced. As a result
of the strategic restructuring, TTCH sold its holdings in Tata Global Beverages to Tata
Sons for a consideration of ~INR9.2b in September 2017. Such restructuring in the
Tata Group will keep significant free cash flows at TTCH’s disposal.
What lies ahead…
Apart from the above, TTCH has other non-core investments amounting to INR16.8b
at its disposal, which could be potentially sold as part of its strategic restructuring.
Exhibit 13:
Non-core investments held by TTCH
Particulars
The Indian Hotels Co. Ltd.
Oriental Hotels Ltd.
Tata Investment Corporation Ltd.
Tata Steel Ltd.
Tata Motors Ltd.
Titan Company Ltd.
Market Value of Non-Core Investments
th
No.
Shares (In m)
8.9
2.5
0.5
2.5
2.0
13.8
Market Price
136
43.7
763.6
578.5
338.8
943.9
Market Value
(In INR m)
1,211.5
110.4
363.4
1,441.7
666.2
13,050.5
16,843.6
Note: Price as on 27 March 2018, Source: Company, MOSL
2 April 2018
10

Tata Chemicals
Potential areas to allocate cash generated from divestment process
Exhibit 14: Potential areas to allocate cash from non-core assets
Repayment of debt
Deploy in specialty &
consumer business
Source: Company, MOSL
Repayment of debt to save interest outgo, boost profitability
The funds received from the sale of the fertilizer business and available cash in hand
could be used to repay debt and to invest in consumer business, leading to savings
in interest expense, and ultimately, increasing earnings. Debt repayment would lead
to 48% reduction in interest cost from INR4.1b in FY17 to INR2.1b in FY20. The
management intends to use the cash from sale of fertilizer business and investments
to retire India debt (INR20.5b in FY17). We assume long-term debt repayment of
INR15b in the standalone entity through the sale of fertilizer business and
investment in Tata Global Beverage. We also assume debt repayment of INR2.5b
each in the US and Europe & Africa businesses in FY18.
Exhibit 15: Transformation into a net debt-free company
Net Debt (INR b)
1.1
0.7
0.1
12.7
-2.1
0.0
3.0
5.3
FY16
FY17
FY18E
FY19E
FY20E
FY16
4.1
Net Debt to Equity Ratio
Exhibit 16: Debt reduction to lower interest expense
Interest Expense (INR b)
Interest Coverage Ratio
8.2
5.3
10.0
78.2
51.9
0.0
4.0
4.1
FY17
3.3
FY18E
2.4
FY19E
2.1
FY20E
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
11

Tata Chemicals
Unleashing the specialty & consumer business potential
Leveraging on Tata Salt’s distribution strength
TTCH has been a pioneer in developing the market for iodized salt in India, and enjoys
a share of 25% in the country's powdered salt market.
It has a distribution network of 1.7m retail outlets, reaching 143m households across
India. Compared to the other prominent FMCG companies in India that have an
average retail reach of 5-6m outlets, we believe TTCH has ample room for growth.
Leveraging on the network, TTCH has expanded its horizons to include branded pulses,
spices, besan (gram flour) and water purifiers, wherein it is yet to realize full potential.
It is also entering nutritional solutions, backed by years of deep understanding and
scientific research. Besides, it is foraying into yet another technology enabled,
differentiated business – highly dispersible silica.
Tata Salt’s sweet success to continue
Estimated annual consumption of edible salt in India is 6m tonnes. Demand for
edible salt is expected to grow at ~1.5%. The market continues to move toward
higher share of branded salt, with increasing awareness about product quality,
visible purity and iodine content. Specialty salts like rock salt and black salt have
increased presence in modern format stores.
Tata Salt continues to be the leader in the national branded salt segment, and ‘I-
Shakti’ is the third-largest brand in terms of market share. TTCH commands a
market share of 25% in the Indian salt market (29% if ‘I-Shakti’ salt brands are also
taken into consideration). Tata Salt Lite continues to be the leading brand in the low
sodium salt segment, and Tata Salt Crystals leads in the crystal salt segment. As the
brand continues to grow, a number of products designed to cater to specific needs
of the consumer have been added to the portfolio in recent years, such as Tata Salt
Lite, Tata Salt Plus and Sprinklers. In FY17, the company launched rock salt and black
salt in attractive crusher formats, which were well received in the launch markets.
Exhibit 17: Bifurcation of salt market in India
Exhibit 18: TATA Salt’s share in India’s salt market
25.2
24.6
24.2
Unbranded
56%
Branded
44%
21.6
FY14
Source: MOSL
FY15
FY16
FY17
Source: Company, MOSL
Salt is likely to deliver sales CAGR of ~5.5% over FY18-20. TTCH’s market share in
some markets is as high as 35-40%, while in some other markets, it is way below
25%. It has lower market share in the South and East – the regions where the
company intends to strengthen focus. TTCH plans to focus on growing its market
share by increasing its distribution reach and manufacturing capacity. It reaches
2 April 2018
12

Tata Chemicals
about 1.6m retail outlets compared to prominent FMCG players’ reach of 5-6m
retail outlets, implying significant headroom for growth. TTCH will increase its
capacity from 1mt to 1.5mt in phases over the next five years. TTCH has also added
team members to fulfill its growth targets. Tata Salt’s distribution has always
focused on wholesale channels. This strategy has led to lower focus on on-ground
sales. TTCH is now shifting its focus from wholesale to retail channels.
Existing salt distribution network to foster growth in consumer business
Tata Salt commands 25% share in the Indian salt market. However, if we consider
only the branded segment, it commands 66% share, clearly a leader in the salt
market in India. Tata Salt reaches 143m households across the country annually. It is
the largest distributed brand, with a reach of 1.7m retail outlets across India. This
could be used to foster growth of consumer products (pulses, spices, nutritional and
other products) in TTCH’s pipeline.
Exhibit 19: TTCH’s salt products range
Source: Company, MOSL
Exhibit 20: TATA Salt revenue and growth
19.0
21.8
Revenue(INRb)
Growth(%)
Exhibit 21: TATA Salt volume and realization
Volume (in '000MT)
12,068
11,199
12,776
Realisation (INR per tn)
11,636
11,521
11,753
11,870
5.4
7.7
10,078
5.2
1.0
-3.8
6.1
5.0
11,499
8.8
10.8
11.3
12.2
11.7
12.4
12.5
13.2
13.9
876
936
940
956
1,049 1,073 1,073 1,127 1,172
Source: Company, MOSL
Source: Company, MOSL
Expanding consumer business horizon through Tata Sampann brand
TTCH, via its Tata Sampann umbrella brand, offers unpolished high protein pulses
range, low-absorb besan (gram flour) made from 100% chana dal, and the uniquely
developed range of spices. The focus is to capitalize on demand for wholesome
food with good taste.
2 April 2018
13

Tata Chemicals
Exhibit 22: Growing number of products in consumer business
No. of products in CPB portfolio
24
27
29
12
FY14
FY15
FY16
FY17
Source: Company, MOSL
Pulses – focus on grade-A stores
The pulses market in India is largely unbranded. However, many business houses
have entered the market over the past few years. Due to the government’s policy
changes for regulating stock movement and prices, there was a downward trend in
the pulses commodity cycle in CY16, because of which branded players suffered.
TTCH has taken necessary steps to eliminate such risks, and intends to focus on
grade-A category of stores.
Exhibit 23: Growing reach of pulses (no. of outlets)
122,000
92,000
128,000
45,000
FY14
FY15
FY16
FY17
Source: Company, MOSL
Exhibit 24: TATA Sampann’s wide portfolio of pulses
Source: Company, MOSL
2 April 2018
14

Tata Chemicals
Besan: TTCH’s differentiated health-focused products ready to tap
opportunity
The besan (gram flour) market is estimated at INR200b, but the product is
associated with guilt, because of its heavy usage in fried snacks. Besan is mostly
used in the making of fried snacks such as pakoras, bhajjis, sev and gathiyas. To
make snacks crispier, they are often deep fried, which leads to higher oil absorption.
This increases the chances of weight gain and other health issues. Therefore,
consumers look for ways to prepare besan snacks with less oil while retaining the
same taste and crispiness. TTCH has launched besan that absorbs less oil and is
healthy.
The besan market is largely unbranded in India, and there is a significant
opportunity to introduce superior branded variants by driving the ‘Low Oil Absorb’
differentiation. The differentiated offering commands up to 10-15% premium over
ordinary unbranded besan. TTCH’s portfolio consists of ‘Tata Sampann Low Oil
Absorb Besan’ and ‘Tata Sampann Fine Besan’. Since the launch in January 2016,
TTCH has achieved volumes of 13,000 tonnes.
Exhibit 25: TATA Sampann – another innovative product in basket
Source: Company, MOSL
Exhibit 26: TATA Sampann’s products on Amazon
Source: Company, MOSL
2 April 2018
15

Tata Chemicals
Exhibit 27: TATA Sampann’s products on Grofers
Source: Grofers, MOSL
2 April 2018
16

Tata Chemicals
Exhibit 28: TATA Sampann’s products on BigBasket
Source: Company, MOSL
Spices: Adding flavor with health-focused objectives
The total branded spices market in India is around INR150b in size. Chilli, turmeric
and coriander account for 80% of the pure spices market. The market is fragmented
and commoditized, with over 3,000 local brands. Garam masala, meat masala,
chicken masala, and kitchen king masala, among others are the popular blends cross
regions.
TTCH has developed a portfolio of four pures (Chilli, Turmeric, Coriander, Shahi Lal
Mirch) and eight blends (Punjabi Chole Masala, Dal Tadka Masala, Kitchen King
Masala, Garam Masala, Meat Masala, Paneer Masala, Chicken Masala and Pav Bhaji
Masala). These are 100% pure and unadulterated, with guaranteed levels of active
ingredients, ensuring the best quality. It is currently present in 16 states, with the
highest market share being in the state of Punjab (around 5%). Going forward, TTCH
plans to scale up the spices business by leveraging TATA Salt’s distribution network
and expanding direct reach to outlets beyond its current coverage. Foraying into the
global markets is also a priority, as the opportunity landscape is widening. New
variants, product formats and customized offerings are consistently being
developed.
2 April 2018
17

Tata Chemicals
Exhibit 29: TATA Sampann spices
Source: Company, MOSL
Exhibit 30: Business value chain for Salt, Pulses, Besan, Spices and Nutritional Solutions
Business Value
Chain Of Products
Raw Material
Processing
Salt
Products
Pulses and Besan
Sea Salt/ Brine Access /
Procurement
Vacuum Evaporated /
Third Party refining
Iodised VE Salt, Tata
Salt, Tata Salt Lite, Tata
Salt Plus, Tata Salt
Crystal, Flavoritz, Rock
Salt, Black Salt, I-Shakti
Salt, I-Shakti Cooking
Soda
Multiple SKUs
at CFAs under HACCP /
FSSAI standards
Sourcing from Farms
and Mandis
Milling / Outsourced
operations
Unpolished Dals/ Low
Oil Absorb Besan, Toor
Dal, Moong Dal, Masoor
Dal, Chana Dal, Urad
Dal, Low Oil Absorb
Besan, Fine Besan, Low
Oil Absorb Pakoda Mix
SKUs of multiple sizes
and dal types
Spices
Nutritional Solutions
Sucrose
Other processing
aids
Biotransformation,
Purification,
Fossence,
Gossence,Tata Nx
Lite & Sweet . Tata
Nx Zero Sugar
Sourcing as per requirements
Processing operations with
business partners
Spices, Chilli, Turmeric,
Coriander, Shahi Lal Mirch,
Punjabi Chole Masala, Dal
Tadka Masala, Kitchen King
Masala, Garam Masala, Meat
Masala, Paneer Masala,
Chicken Masala, Pav Bhaji
Masala
5 sachets in a pack format
Road
Packaging
Logistics
Distribution
Same distribution
channel as salt would
act as a catalyst to
foster growth
End Use
Through Rail and Road Road
1. Distributor
To Stockist and
To Retailer
2. Institution
3. Dal on Call
Household
Warehouse
1. Distributor
To Stockist and
To Retailer
2. Institution
Household
1. Distributor
To Stockist and
To Retailer
2. Institution
3. Dal on Call
Household
Warehouse
Industries - Bakery,
Confectionary,
Nutraceuticals
Source: Company
2 April 2018
18

Tata Chemicals
Expanding horizons of speciality – nutraceuticals to
enable flight
Huge opportunity to change Tata Chemical’s business dynamics
TTCH would focus on both B2B and B2C space in the nutraceuticals industry, aiming at
bulk supply to global as well as domestic companies. Its plant at Nellore, Andhra
Pradesh is likely to commence in 4QFY19 and commercialization is expected in
1QFY20.
We estimate the size of the B2B global nutraceuticals industry at ~USD60b in 2016,
growing to ~USD92b in 2021.
We expect the segment to generate EBITDA margin of 24-25%, with RoCE at 20-25%.
Global nutraceuticals market to grow at CAGR of 7.5% over 2016-21
Nutraceuticals are food or fortified food products that not only supplement the diet
but also assist in treating or preventing disease, providing medical benefits. The
nutraceutical market mainly constitutes functional foods and beverages and dietary
supplements. Dietary supplements are present in the form of tablets, capsules and
liquids. The nutraceutical ingredients include pre-biotic and pro-biotic vitamins,
minerals, fibers, proteins, omega-3 and structured lipids, amino acids, and various
other ingredients.
Nutraceutical ingredients find application right from cereals, grains, nuts,
vegetables, fruits, dairy products, poultry products, sea food and confectionery
items to non-alcoholic beverages like juices, energy drinks, sports drinks, etc. Few
examples of functional foods are yogurts with pro-biotics, drinks with herb blends,
soya beverages rich in proteins, etc. The functional food category is seeing the
highest growth in energy drinks, healthy snacks and breakfast products.
According to Research & Markets, the B2C global nutraceuticals industry is valued at
USD198.7b (in 2016). It is expected to grow at a CAGR of 7.5% over 2016-21 to
USD285b. The functional global beverages market was valued at USD71.5b in 2016
and is expected to grow at a CAGR of 8.1% over 2016-21 to USD105b. The functional
global food market was valued at USD64.6b in 2016 and is expected to grow at a
CAGR of 7.4% over 2016-21 to USD92.3b.
Currently, the US, Europe and Japan account for most (93%) of the total global
nutraceuticals market. The market, however, seems to have attained maturity in all
the three regions. Therefore, the nutraceutical players across the world are now
turning their attention to emerging markets like India and China. India is one of the
most rapidly-growing nutraceuticals markets in the Asia-Pacific region. According to
ASA & Associates, the nutraceuticals industry in India was worth about USD2.2b in
2015 and is estimated to grow at a CAGR of 20% over 2019-20 to USD6.1b.
2 April 2018
19

Tata Chemicals
Focus on nutraceuticals space to transform Tata Chemicals
TTCH’s nutritional solutions plant at Nellore, Andhra Pradesh is likely to commence
in 4QFY19 and commercialization is expected in 1QFY20. The company intends to
set up a state-of-the-art biotechnology unit with a capacity of 5,000TPA and the
capex for the plant will be INR2.7b. The plant is for manufacturing of fructo-
oligosaccharides (FOS), a natural sweetener used in infant milk powder, cereals &
dairy, and galacto oligosaccharide (GOS), which belong to the group of prebiotics.
TTCH is entering into the B2B space of nutraceuticals, with focus on bulk supply to
overseas companies. It has already built a global supply chain and relationships
across the globe. We estimate the size of the B2B market at ~USD60b (assumed cost
of goods sold of global B2C players) in 2016. Assuming similar growth of 7.5% in the
global B2C nutraceuticals industry, the B2B market is estimated to reach USD92b in
2021.
We did a scenario analysis assuming asset turnover of 1.5x and 2x. According to our
analysis, EBITDA margin of the business would be 24% (at 1.5x asset turnover, and
assuming RoCE of 20% and working capital to sales at 35%) in Scenario-1 (refer
exhibit-33) and 25% (at 2x asset turnover, and assuming RoCE of 25% and working
capital to sales at 40%) in Scenario-2 (refer exhibit-33).
At the current planned capacity, the nutritional solutions segment is expected to
contribute 3-4% to consolidated sales and 4-5% to consolidated EBITDA (refer
exhibit 31 & 32). Assuming doubling of capacity, the segment is expected to
contribute 7-9% to consolidated sales and 8-10% of consolidated EBITDA. Assuming
tripling of capacity, the segment is expected to contribute 10-13% of consolidated
sales and 11-15% of consolidated EBITDA with global B2B market share at just 0.3%.
Exhibit 31: Case-I (Asset turnover 1.5x)
Scenario
Current capacity (5000 TPA capacity) (Announced)
Scenario 1 (10,000 TPA capacity)
Scenario 2 (15,000 TPA capacity)
Revenue
(INR m)
4125
8250
12375
EBITDA
(INR m)
1100.0
2200.0
3300.0
Global Market
Share
0.07%
0.14%
0.21%
Contribution to Contribution to
Consolidated
Consolidated
sales
EBITDA
3%
7%
10%
4%
8%
11%
Source: Company, MOSL
Exhibit 32: Case-2 (Asset turnover 2x)
Scenario
Current capacity (5000 TPA capacity) (Announced)
Scenario 1 (10,000 TPA capacity)
Scenario 2 (15,000 TPA capacity)
Revenue
(INR M)
5,500
11000
16500
EBITDA
(INR M)
1375.0
2750.0
4125.0
Global Market
Share
0.09%
0.18%
0.28%
Contribution to Contribution to
Consolidated
Consolidated
sales
EBITDA
4%
5%
9%
10%
13%
15%
Source: Company, MOSL
2 April 2018
20

Tata Chemicals
Exhibit 33: Tata Chemical’s Nutritional Solutions segment Profit & Loss A/C (Estimated)
INR Mn
Net block
Working Capital (as % of sales)
Working capital
Capital employed
RoCE
Asset Turnover
EBIT
Revenue
Depreciation
EBITDA
EBITDA Margin
Scenario I (Asset turnover 1.5x)
2,750
35%
1,443.8
4,194
20%
1.5
838.75
4,125
138
976
24%
Scenario II (Asset Turnover 2x)
2,750
40%
2,200
4,950
25%
2.0
1,238
5,500
138
1,375
25%
Source: Company, MOSL estimates
Seeding the specialty and nutritional portfolio
TTCH’s innovation center (IC) in Pune supports the diverse needs of its businesses
along with synergistic programs with Tata Group companies. The nutritional
solutions unit, operating as a start-up, will focus on building scale in the specialty
businesses. MoU was signed with the Andhra Pradesh government to invest
INR2.75b for a greenfield biotechnology manufacturing unit for food ingredients and
formulations developed at TTCH’s IC. During the year, the IC developed a highly
dispersible silica formulation that is suitable for tyre applications, and the company
is planning to manufacture precipitated highly dispersible silica (HDS) in Gujarat.
The nutritional solutions business unit offers optimal nutrition through dietary
solutions in the form of highly differentiated, science-based innovative ingredients
and formulations. TTCH’s bio-easy platform brings together knowhow of
biogenomics, food technology, material sciences and biotechnology to ensure that
the right nutrient is delivered in the right way to the consumer. This involves
collaboration and co-creation with customers in a project mode.
FY17 was the second full year of operations of the greenfield proof-of-concept
manufacturing unit at Sriperumbudur near Chennai. During the year, the unit
produced several grades of fructo-oligosaccharides (FOS) and FOS-based
formulations and sold a total of 680 tonnes of FOS across India. Albeit being a new
product, it has garnered wide acceptance as a prebiotic healthy sweetener for
categories such as dairy, bakery and confectionery. Based on market requirements
and formulation capabilities, the business has introduced new variants of healthier
and natural sweeteners that are alternatives to cane sugar for both institutional and
retail segments. Additionally, at the request of key customers and to leverage
synergies with company-manufactured products and formulations, complementary
products were added to the product portfolio. In FY17, the business achieved a
turnover of INR269m, more than 300% increase over the previous year.
2 April 2018
21

Tata Chemicals
Exhibit 34: Artificial sweeteners
Source: Company, MOSL
During the year, TTCH initiated critical clinical studies and technology ramp-up for
downstream processing and spray drying. The business has also initiated market
seeding with customers in the US to gain insights; this will aid business development
efforts in anticipation of the upcoming commercial-scale 5,000 tonnes
manufacturing unit at Nellore, Andhra Pradesh.
2 April 2018
22

Tata Chemicals
HDS – a future technology for tyre industry
Tata Chemicals on right track, with filing of eight patents
Highly dispersible silica (HDS) is a substitute for carbon black, which has an INR50b
market in India. It scores over carbon black on various parameters – reduced rolling
resistance, reduced emissions and better aesthetic appeal.
TTCH is set to manufacture HDS, with an initial capacity of 50,000TPA, which will
enable it to grab ~12% share in India’s HDS market at full utilization.
Assuming fixed asset turnover of 1.5x and RoCE of 20%, we expect HDS business to
generate a revenue of ~INR4.5b in first year of operations, with a margin of ~23%.
HDS – impressive prospects
HDS is a product used in tyres, primarily for rubber reinforcements. It is expected to
benefit the tyre industry by lowering rolling resistance for improved vehicle fuel
economy, reducing greenhouse gas emissions, increasing traction for improved
safety/handling and improving wear resistance compared to traditional compounds.
In addition, HDS has an aesthetic appeal, wherein it can be mixed with different
colours – it acts as a catalyst for the preparation of tyres in different colors.
The current compound used in tyres for the same purposes is carbon black. It
constitutes almost 13% of a tyre’s total cost. In the near future, HDS has a good
chance to replace carbon black and become an important input material in new-age
tyre manufacturing. In 2016, the market size of carbon black in India was INR50b.
Exhibit 35: HDS scores over carbon black
HDS
Expensive than Carbon black
Better performance
Increased fuel efficiency
Environment and human friendly
Carbon Black
Cheaper to produce
Lower performance
Lower efficiency
Carcinogenic (Cancer Causing)
Source: Company, MOSL
HDS segment margin likely to be in the range of 22-23%
TTCH is setting up a manufacturing unit in Gujarat for precipitated HDS, mainly used
in the rubber and tyre industries, with a total capacity of 50,000TPA. The total
investment will be INR2.95b. Trial runs are expected to commence in 4QFY19 and
commercialization is likely in 1QFY20. Technology for the HDS has been developed
at the IC (innovation center) in Pune, for which eight patents have already been
filed. We expect the company to grab ~12% share in India’s HDS market at full
capacity utilization. We estimate EBITDA margin of the business at 22-23%,
assuming RoCE of 20-25%.
2 April 2018
23

Tata Chemicals
Exhibit 36: Tata Chemical’s HDS business Profit & Loss a/c (estimated)
Particulars (INR Mn)
Net block
Working Capital (as % of sales)
Working capital
Capital employed
RoCE
Asset Turnover
EBIT
Revenue
Depreciation
EBITDA
Margin
Scenario I (Asset turnover 1.5x)
2,950
30%
1,327.5
4,278
20%
1.5
855.5
4,425
147.50
1,003
23%
Scenario II (Asset Turnover 2x)
2,950
30%
1,770.0
4,720
25%
2.0
1,180
5,900
147.50
1,328
23%
Source: Company, MOSL estimates
2 April 2018
24

Tata Chemicals
Soda ash to show steady performance
Cost advantage over its peer, as 70% of capacity is natural soda ash
TTCH’s soda ash realizations have seen robust growth over FY12-17 across
geographies: 6% in India, 11% in Europe, 8% in North America, and 5% in Africa.
However, volume decline led to flattish growth in consolidated soda ash revenue.
Going forward, we expect consolidated soda ash revenue to grow at a CAGR of 5%
over FY17-20, driven by both volume and realization growth.
World’s second largest soda ash manufacturer
With a capacity of ~4.2m MT of soda ash and 0.2m MT of sodium bicarbonate across
its manufacturing facilities in India, UK, Kenya and US, TTCH has a competitive
advantage of being the world’s most geographically diversified soda ash company.
Almost 70% of its soda ash capacity is manufactured via the natural route. The
plants at Mithapur (India), Wyoming (the US), Northwich (the UK) and Magadi
(Kenya) have their own unique operational philosophy.
Exhibit 37: TTCH’s operations in various geographies across the globe
Name of the
company
Type of soda ash
Place of operations
TATA
Chemicals India
Raw Material
Synthetic
India
Limestone, coke,
coal, natural gas,
CO2, Ammonia
Road, Rail and sea
Direct 73%, Channel
Partners 27%
Mithapur:
It is an
integrated inorganic
chemicals complex,
manufacturing soda
ash, edible salt,
sodium bicarbonate,
cement, marine and
caustic chemicals.
TATA Chemicals
North America Inc.
Natural
United States of
America
Coal, Natural gas,
HFO
Road, Rail and sea
Direct 73%, Channel
Partners 27%
Wyoming:
Manufacturing facility
consists of an
underground trona
mine and a surface
refining plant that
processes the ore
into soda ash.
TATA Chemicals
Europe Holdings Limited
Synthetic
United Kingdom
Limestone, coke,
coal, natural gas,
CO2, Ammonia
Road, Rail and sea
Direct 73%, Channel
Partners 27%
Northwich:
It is one
of the continent’s
leading producers of
sodium carbonate,
soda ash, salt, sodium
bicarbonate and
other products.
TATA Chemicals
Magadi
Natural
South Africa
Coal, Natural gas,
HFO
Road, Rail and sea
Direct 73%, Channel
Partners 27%
Magadi:
It is Africa’s
largest soda ash
manufacturer and
one of Kenya’s
leading exporters. At
the facility, soda ash
is obtained by
washing and calcining
trona, a naturally
occurring form of
sodium
sesquicarbonate,
extracted from Lake
Magadi in Kenya.
Source: Company, MOSL
Logistics
Distribution
Unique operation
philosophy
2 April 2018
25

Tata Chemicals
Exhibit 39: Consolidated soda ash volume and realization
per tonne
Volume (In mn tn)
19.5
18.8
18.1
19.0
Avg realisation per tonne (In 000's)
19.5
Exhibit 38: TTCH soda ash revenue mix by geography
India
22%
22%
23%
22%
23%
North America
47%
46%
46%
46%
43%
Europe
22%
22%
21%
23%
24%
Africa
10%
10%
10%
8%
3.6
10%
FY16
3.7
FY17
3.8
FY18E
3.9
FY19E
4.0
FY20E
Source: Company, MOSL
Source: Company, MOSL
Note: Europe revenue includes soda ash, sodium bicarbonate, salt and power
Global/Indian soda ash market to remain steady
Emerging economies, especially China, have been the primary growth drivers for
soda ash over the past decade, with increasing glass and detergent usage. However,
the year 2016 saw demand slowing down in China, with an estimated growth rate of
less than 1%. Several other regions, including the developed markets of North
America and Europe, however, showed relatively healthy growth during the year.
Global soda ash demand in 2016 is estimated to have grown ~1.9% to reach 56.6m
tonnes.
Global demand is expected to grow at 2.1% annually through 2026.
Indian market demand growth increased by ~7% in FY16-17, after almost flat
volumes in the previous year. North American volumes are expected to be flat, with
the exception of incremental demand from Mexico’s container glass industry. US
exports are likely to face stiff competition from new production from Turkey and
Russia. The UK market remained reasonably flat for the year, with Tata Chemicals
Europe retaining its market leadership, leveraging production based out of both the
UK and US manufacturing facilities. Demand growth in the key markets of the
company’s African operations remained mixed.
Global soda ash capacity is estimated to have grown marginally by ~0.5m tonnes in
FY17. Regional overcapacity and tightening governmental policies resulted in
continued consolidation in China, leading to capacity remaining almost flat in FY16-
17. However, capacity addition occurred in other regions, including the Indian
subcontinent, the Middle East and Central Europe.
Global capacity is expected to
grow at 2.1% annually through 2026, with Turkey leading capacity addition.
India
continues to be a significant importer of soda ash, with 0.75m tonnes of imports in
FY16-17. While the Indian market is supplemented by soda ash from the US and
Kenya, UK demand is also catered to by substantial imports from the US.
2 April 2018
26

Tata Chemicals
Exhibit 40: Soda ash uses globally (2017)
Glass
17
2
2
3
13
12
52
Inorganic Chemicals
Soaps & Detergents
Organic Chemicals
Paper & Pulp
Alumina
Others
Source: Bloomberg, MOSL
Source: MOSL
Dense (used in
glass
manufacturing)
Washing Soda
(used in detergents
and soaps)
Light Soda Ash
(used as ph
regulator in
industrial uses)
Exhibit 41: Types of soda ash
Soda Ash
Exhibit 42: Global soda ash demand to grow at a CAGR of 2.1% over 2016-26 (m tonnes)
57.9
2011A
58.7
2012A
58.9
2013A
60.2
2014A
61
2015A
61.9
2016E
74.4
2026E
Source: IHS and USGS Soda Ash, MOSL
Exhibit 43: Global soda ash capacity mix (%)
2012
5.3
2017
7
2021
9.3
6.7
0.5
46
11.9
6.1
0.4
45.2
6.4
1.1
14.6
5.7
0.4
0
43.8
13
6
0
7
22.7
21
20.0
Source: Company, MOSL
2 April 2018
27

Tata Chemicals
Exhibit 44: Global soda ash consumption mix (%)
2012
2017
2021
11
3
14
7
4
6
42
3
14
12
12
7
43
2
13
12
7
45
7
4
7
11
4
11
Source: Company, MOSL
Exhibit 45: Soda ash production process and its relative cost advantage
Source: Bloomberg, MOSL
2 April 2018
28

Tata Chemicals
Exhibit 46: Soda ash production process capacity (2016) mix
Other global natural, 2%
Other synthetic, 8%
Hou, 22%
US Natural, 20%
Solvay, 48%
Searless, 10%
Ciner, 19%
Genesis,
28%
Tata, 20% Solvay, 23%
Source: IHS and USGS Soda Ash, MOSL
Exhibit 47: Soda ash price in India (INR per 50kg)
1,500
1,400
1,300
1,200
1,100
Exhibit 48: Soda ash price in China (USD per tonne)
350
300
250
200
150
Source: Bloomberg, MOSL
Source: Bloomberg, MOSL
Exhibit 49: Soda ash price in Europe (USD per tonne)
340.0
310.0
280.0
250.0
220.0
Exhibit 50: Soda ash price in US (USD per tonne)
227.0
219.0
211.0
203.0
195.0
Source: Bloomberg, MOSL
Source: Bloomberg, MOSL
2 April 2018
29

Tata Chemicals
Exhibit 51: Sodium bi-carbonate price in India (per 50kg)
1,800
1,600
1,400
1,200
1,000
Source: Bloomberg, MOSL
Exhibit 52: Ammonia price in India (USD per tonne)
750
625
500
375
250
125
0
Exhibit 53: Ammonia price in Middle East (USD per tonne)
750
625
500
375
250
125
0
Source: Bloomberg, MOSL
Source: Bloomberg, MOSL
Exhibit 54: Indonesian coal price (6322 KCAL)/tonne
120
95
70
45
20
Exhibit 55: Natural gas price (Henry Hub; USD/MMBTU)
6.0
4.5
3.0
1.5
0.0
Source: Bloomberg, MOSL
Source: Bloomberg, MOSL
Consolidated soda ash business to show steady performance
TTCH’s consolidated soda ash and sodium bicarbonate revenue was almost flat over
FY15-17. Realization grew at a CAGR of 1.8% and sales volume declined at 1.63% per
year. EBITDA grew at a CAGR of ~4%.
We expect consolidated soda ash and sodium bicarbonate revenue to grow at a
CAGR of 5% over FY17-20 to INR81.9b. Sales volume is likely to grow at a CAGR of
2% to 4.1m tonnes and realization at a CAGR of 2% to INR19,610/tonne. EBITDA is
expected to grow at a CAGR of 7% to INR17.2b and EBITDA/ton at a CAGR of 5% to
INR4,111.
2 April 2018
30

Tata Chemicals
India soda ash business to grow at healthy pace
Soda ash revenue grew at a CAGR of 7% over FY12-17, driven by higher realization.
Realization grew at a CAGR of 6% and sales volume grew at a CAGR of 1%.
We expect revenue to grow at a CAGR of 3% over FY17-20 to INR17.2m. Sales
volume would grow at a CAGR of 1% and realization would grow 2%.
Exhibit 56: India soda ash volume and growth
Volume (in '000 tonnes)
2.6
1.5
0.8
-0.2
-0.9
674
FY12
691
FY13
690
FY14
683
FY15
685
FY16
708
FY17
714
FY18E
724
FY19E
739
FY20E
0.3
0.8
Growth (%)
3.4
2.0
Exhibit 57: India soda ash revenue and growth
18.6
Revenue(INRb)
Growth (%)
15.0
10.7
6.8
1.9
-3.3
11.2
FY12
13.3
FY13
13.6
FY14
15.0
FY15
16.0
FY16
15.5
FY17
15.6
FY18E
16.3
FY19E
17.2
FY20E
0.9
4.5
5.1
Exhibit 58: India soda ash realization per tonne and growth
Realisation (INR/tonne)
14.1
15.6
11.7
2.2
6.5
0.1
-6.4
16,637
FY12
19,233
FY13
19,647
FY14
21,952
FY15
23,390
FY16
21,882
FY17
21,904
FY18E
22,561
FY19E
23,238
FY20E
3.0
3.0
Growth (%)
2 April 2018
31

Tata Chemicals
Exhibit 59: India soda ash scenario
3.4
Soda Ash India (in m tonnes)
2.8
0.75
0.03
Installed Capacity
Production
Imports
Exports
Source: Company, Ministry of Commerce and Industry, various industry sources
Exhibit 60: Soda ash market share mix in India
Import, 23%
Tata Chemicals,
20%
Others, 5%
Nirma, 27%
GHCL, 25%
Source: Company and various industry sources
Tata Chemicals Europe likely to show steady performance
TCEHL (Tata Chemicals Europe Holdings Limited) revenue grew at a CAGR of 2% over
FY12-17, driven by higher realization. Realization grew at a CAGR of 11% and sales
volume declined at 8% per year. For TCEHL, the realization is a blended mix of soda
ash, sodium bi-carbonate, salt and power. EBITDA declined at 4% per annum over
FY12-17.
We expect revenue to grow at a CAGR of 2% over FY17-20 to INR17.3b. While sales
volume would grow at a CAGR of 0.4%, realization would grow at a CAGR of 2%.
EBITDA is expected to grow at a CAGR of 2.9% to INR2.5b. EBITDA/tonne is expected
to improve from GBP45 in FY17 to GBP48 by FY20.
Exhibit 61: TCEHL’s revenue mix (FY15)
Power, 21%
Salt, 19%
Soda Ash &
Sodium
Bicarbonate, 60%
Source: Company, MOSL
2 April 2018
32

Tata Chemicals
Exhibit 62: TCEHL’s revenue and growth
22.5
10.3
15.0
7.6
-6.2
14.5
FY12
16.0
FY13
18.4
FY14
17.3
FY15
-1.9
-4.7
8.6
Revenue(INRb)
Growth
-8.1
14.8
FY18E
16.0
FY19E
17.3
FY20E
17.0
FY16
16.2
FY17
Source: Company, MOSL
Exhibit 63: TCEHL’s total sales volume and growth
Total Sales Volume (in '000 Tonnes)
-4.2
-23.2
-0.7
Growth (%)
-1.0
-7.1
4.0
4.8
-8.7
887
FY12
810
FY13
776
FY14
596
FY15
592
FY16
586
FY17
544
FY18E
566
FY19E
593
FY20E
Note: Europe sales – total sales volume includes soda ash and sodium bicarbonate
Source: Company, MOSL
Exhibit 64: TCEHL’s realization and growth
31.1
20.8
20.1
Realisation (INR/tonne)
22.1
3.5
3.6
Growth (%)
-1.2
-3.7
27,560
FY17
-1.1
16,374
FY12
19,779
FY13
23,751
FY14
28,993
FY15
28,632
FY16
27,263
FY18E
28,220
FY19E
29,236
FY20E
Note: Europe sales – realization includes soda ash, sodium bicarbonate, salt and power
Source: Company, MOSL
Exhibit 65: TCEHL’s soda ash sales volume and growth
Sales Volume ('000 tonnes) soda ash
-3.5
-3.7
Growth (%)
5.0
-7.5
-2.2
-10.0
-26.0
785
FY12
716
FY13
691
FY14
511
FY15
492
FY16
481
FY17
433
FY18E
455
FY19E
482
FY20E
-8.8
6.0
Source: Company, MOSL
2 April 2018
33

Tata Chemicals
Exhibit 66: TCEHL sodium-bi-carbonate sales volume and growth
Sales Volume ('000 tonnes) sodium bi-carbonatre
17.6
2.0
-7.7
102
FY12
94
FY13
-10.0
85
FY14
85
FY15
100
FY16
105
FY17
111
FY18E
111
FY19E
111
FY20E
0.5
5.0
6.0
0.0
0.0
Growth (%)
Source: Company, MOSL
Exhibit 67: TCEHL’s EBITDA/tonne
EBITDA/tonne (GBP)
EBITDA/tonne (INR)
2770
1242
-219
13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
28
45
46
4244
48
3942
3869
4051
47
Source: Company, MOSL
Tata Chemicals North America operating performance likely to improve
Tata Chemicals North America (TCNA) revenue grew at a CAGR of 7% over FY12-
FY17, driven by higher realization. Realization grew at a CAGR of 8% and sales
volume declined at 1% per annum. EBITDA grew at a CAGR of 1% over FY12-17.
We estimate 5% CAGR in revenue over FY17-20 to INR37b. Sales volume would grow
at a CAGR of 2% and realization at 2.7%. EBITDA is expected to grow at a CAGR of
9% to INR8b. EBITDA/tonne is expected to grow at a CAGR of 6.3% in INR terms to
INR3,385 and at a CAGR of ~5% in USD terms to USD50.
Exhibit 68: TCNA revenue and growth
26.8
Revenue(INRb)
Growth (%)
13.0
12.5
3.2
5.9
-0.3
30.1
FY16
31.9
FY17
0.1
32.0
FY18E
34.4
FY19E
37.1
FY20E
7.7
7.8
23.1
FY12
26.0
FY13
29.3
FY14
30.2
FY15
Source: Company, MOSL
2 April 2018
34

Tata Chemicals
Exhibit 69: TCNA realization and growth
27
Realisation (INR/tonne)
15
10
4
-1
9,705
FY12
11,116
FY13
12,261
FY14
12,800
FY15
14,331
FY16
14,250
FY17
-3
13,846
FY18E
14,616
FY19E
15,442
FY20E
Growth (%)
12
6
6
Source: Company, MOSL
Exhibit 70: TCNA sales volume and growth
Volume (in '000 tonnes)
2
Growth (%)
7
0
3
-1
-11
2376
FY12
2343
FY13
2390
FY14
2363
FY15
2104
FY16
2241
FY17
2308
FY18E
2354
FY19E
2401
FY20E
-1
2
2
Source: Company, MOSL
Exhibit 71: Realization of Ciner v/s TCNA (per tonne)
Ciner
202
188
204
203
182
209
219
TCNA
212
215
221
228
177
183
174
184
2012
2013
2014
2015
2016
2017
2018
2019
2020
NOTE: Ciner is the world’s largest natural soda ash producer, with a capacity of ~5.9m tonnes.
Source: Company, MOSL
Exhibit 72: EBITDA/tonne of Ciner v/s TCNA
58
Ciner
TCNA
52
49
50
48
46
51
47
42
43
43
48
49
50
42
2012
2013
2014
2015
2016
2017
2018
2019
2020
Source: Company, MOSL
2 April 2018
35

Tata Chemicals
Tata Chemical Africa operating performance to improve
TCML’s (Tata Chemicals Magadi Limited) revenue declined at 2% per annum over
FY12-17, driven by lower sales volume. Realization grew at a CAGR of 5% and sales
volume declined at 11% per annum. EBITDA declined at 14% per annum over FY12-
17 to INR0.5b.
We expect revenue to grow at a CAGR of 10% over FY17-20 to INR7.8b. Sales
volume would grow at a CAGR of 8% and realization at a CAGR of 2%. EBITDA is
expected to grow at a CAGR of 33% to INR1.2b. EBITDA per tonne is expected to
grow at a CAGR of ~23% over FY17-20 to INR3,453 (USD51).
Exhibit 73: TCML’s revenue and growth
28.0
11.9
-1.3
-3.3
2.4
-15.7
6.4
FY12
6.3
FY13
7.0
FY14
6.8
FY15
7.0
FY16
5.9
FY17
6.9
FY18E
7.4
FY19E
7.8
FY20E
Revenue(INRb)
Growth
17.3
7.7
5.7
Source: Company, MOSL
Exhibit 74: TCML’s realization/tonne and growth
Realisation (INR/tonne)
35.9
16.9
-3.2
-11.1
17,773
FY15
15,792
FY16
-6.7
14,739
FY17
-2.6
4.5
4.6
Growth (%)
26.2
11,556
FY12
13,503
FY13
13,077
FY14
14,350
FY18E
15,000
FY19E
15,694
FY20E
Source: Company, MOSL
Exhibit 75: TCML’s sales volume and growth
Volume (in '000 tonnes)
14.2
0.4
-12.1
-38.0
484.6
FY12
426.0
FY13
486.4
FY14
301.7
FY15
307.0
FY16
272.0
FY17
327.8
FY18E
337.6
FY19E
341.0
FY20E
1.8
-11.4
Growth (%)
20.5
3.0
1.0
Source: Company, MOSL
2 April 2018
36

Tata Chemicals
Exhibit 76: TCML’s EBITDA/MT
EBITDA/tonne (INR)
45
-5
42
-10
2552
57
3713
2146
27
1838
EBITDA/tonne (USD)
50
3201
50
3300
51
3453
-258
-596
Source: Company, MOSL
World’s fourth-largest sodium bicarbonate producer; sound long-term
fundamentals
Sodium bicarbonate is commonly used as an ingredient in leather tanning, dyes and
textiles, food additives, animal feed, pharmaceuticals, and air pollution control.
TTCH is the world’s third largest producer of sodium bicarbonate, with ~6% capacity
share – it is the market leader in India and the UK. Sodium bicarbonate demand in
India grew ~7% in FY16-17, as against ~4% growth in the previous year. The key
drivers of demand included food, feed and other industrial applications. TTCH
continues to believe in the long-term sound fundamentals of this business, and
maintains a market share in excess of 50%. Going forward, the company plans to
focus on developing and delivering new value-added offerings to its customers. Tata
Chemicals Europe retained its market share in the UK with increasing exports
volumes, which was also helped by the weakening sterling.
Exhibit 77: TTCH India’s sodium bicarbonate revenue
Sodium Bi-carbonate (INR b)
13
7
2.4
5
2.5
89
FY16
FY17
FY18E
FY19E
FY20E
FY16
20.8
94.0
FY17
97.8
FY18E
102.6
FY19E
110.9
FY20E
Growth (%)
22.2
Exhibit 78: TTCH India’s volume and realization per tonne
Volume (In 000's tonnes)
Avg realisation per tonne (In 000's)
21.4
21.6
21.2
2.0
-1
2.0
2.2
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
37

Tata Chemicals
Farm inputs continue to aid growth
New product launches to provide necessary boost
Rallis India – presence across the value chain
TTCH’s subsidiary, Rallis India is one of India’s leading agrochemical companies, with
a comprehensive portfolio of crop protection products, plant growth nutrients,
seeds, crop services and contract manufacturing. Rallis is closely connected to over
1m farmers through the Rallis Kisan Kutumb Program.
Exhibit 79: Consolidated revenue to grow at a CAGR of 11%
over FY17-20E
17.4
Revenue(INRb)
19.8
4.3
-10.6
12.7
FY12
14.6
FY13
17.5
FY14
18.2
FY15
16.3
FY16
17.4
17.9
20.6
23.7
2.1
2.1
2.7
2.8
2.3
2.6
2.7
3.1
3.9
6.8
Growth (%)
15.0
3.0
15.0
16.4
15.7
14.6
15.5
14.1
15.2
15.3
15.3
Exhibit 80: EBITDA margin expands 60bp over FY13-17
EBITDA(INRb)
EBITDA margin (%)
16.3
14.4
FY17 FY18E FY19E FY20E
Source: Company, MOSL
FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E
Source: Company, MOSL
Metahelix – a focused Hybrid seeds company
Metahelix, a subsidiary of Rallis India, is an agricultural biotechnology company
focusing on developing traits and technologies to improve productivity. Hybrid
seeds and traits are commercialized. Metahelix also exports its seeds to selected
countries. The current portfolio of products includes hybrid and research varieties of
various field crops (such as paddy, maize, pearl millet and Bt cotton) and vegetable
crops (such as tomato, hot pepper, okra, green peas and coriander). With significant
improvements in the market shares, it has narrowed the gap with the second largest
player in hybrid rice, and retained the second position in millet. In maize, it has
significantly improved its position, with growth of 35% in sales volumes over the
previous year. In addition to the strong business performance, Metahelix during the
year further strengthened its brand presence, helping it to realize better prices in
the market. On the seed production front, it strengthened its supply capabilities
with the addition of newer locations. During the year, Metahelix launched 11
products.
2 April 2018
38

Tata Chemicals
SWOT Analysis
Second largest and
most diversified soda
ash producer in the
world
25% share of Indian
salt market
Leveraging TATA
brand
Saturated soda
market, low scope for
growth
Due to global
operations, company
is exposed to foreign
exchange risk
HDS, FOS and GOS
products are relatively
niche and could prove
to be major success
factors
Chinese supply glut in
soda ash globally, which
can be beneficial for
current players
Ample headroom to
increase distribution
network
Decrease in cost of
production of synthetic
soda ash threatens
benefits from producing
natural soda ash
Sudden increase in soda
ash capacity from
Turkey disrupting
market dynamics
Increasing competition
in salt business
2 April 2018
39

Tata Chemicals
Bull & Bear case
Bull case
Bear case
In the bull case, we have assumed higher sales growth (driven by an increase in
price/volume) and operating margins.
We had assumed 477bp EBITDA margin improvement over FY17-20 in the base
case. However, on account of a decline in raw material prices in our bull case
assumptions and benefits from economies of scale, we are assuming a 557bp
YoY improvement over FY17-20.
In the bull case, we assume that the company will not pass on the benefit of
lower raw material prices, and thus, enjoy higher margins. We also estimate a
drop in natural gas & coal prices and lower freight costs, benefiting (i) exports
from North America, (ii) UK and India operations, a net importer.
Further, the implied EV/EBITDA multiple is 10.9x FY20E v/s 9.7x in our base case,
considering faster growth in the consumer business.
Carrying the above assumptions, we get a bull case target price of INR1,147
(upside of 66%) based on FY20E EBITDA (v/s base case target price of INR940,
upside of 36%).
In the bear case, we have assumed lower sales growth (driven by decrease in
volume/ price) and operating margins over FY18-20.
We are assuming EBITDA margin contraction of 170bp over FY18-20.
We assume an increase in natural gas and coal prices beyond the current levels.
Additionally, we assume that the company is unable to pass on the price
increase, leading to margin compression.
In our bear case, the implied EV/EBITDA multiple is 8.3x FY20E v/s 9.7x in our
base case, assuming the consumer business fails to pick up.
Carrying the above assumptions, we get a bear case target price of INR683
(downside of 1%) based on FY20E EBITDA (v/s base case target price of INR940,
upside of 36%).
Exhibit 81: Scenario analysis – bull case
Bull Case
Sales (INR m)
Sales growth (%)
EBITDA (INR m)
EBITDA Margin (%)
EBITDA growth (%)
PAT (INR m)
PAT Margin (%)
PAT growth (%)
EPS (INR)
Implied EV/EBITDA (x)
Target price (INR)
Upside/downside (%)
FY18E
1,05,804
-20.4
22,854
21.6
2.8
9,958
9.4
0.3
34.3
FY19E
1,16,775
10.4
25,924
22.2
13.4
12,088
10.4
21.4
47.4
FY20E
1,29,190
10.6
28,809
22.3
11.1
14,030
10.9
16.1
55.1
10.9
1,147
66
Source: Company, MOSL
Exhibit 82: Scenario analysis – bear case
Bear Case
Sales (INR m)
Sales growth (%)
EBITDA (INR m)
EBITDA Margin (%)
EBITDA growth (%)
PAT (INR m)
PAT Margin (%)
PAT growth (%)
EPS (INR)
Implied EV/EBITDA (x)
Target price (INR)
Upside/downside (%)
FY18E
1,05,804
-20.4
22,748
21.5
2.3
9,881
9.3
-0.5
34.0
FY19E
1,13,806
7.6
22,875
20.1
0.6
9,853
8.7
-0.3
38.7
FY20E
1,22,359
7.5
24,227
19.8
5.9
10,642
8.7
8.0
41.8
8.3
683
(1)
Source: Company, MOSL
2 April 2018
40

Tata Chemicals
Transition into a net debt-free entity by FY20
Core RoCE to improve from 11% to 18% over FY17-20
We expect TTCH to deliver revenue CAGR of 9.3% over FY18-20, with the specialty
and consumer (S&C) business driving growth. The S&C business is expected to grow
at a CAGR of 14% over FY18-20. We expect EBITDA margin to expand 467bp from
16.7% in FY17 to 21.4% in FY18 and remain at 21.5% over FY19-20. TTCH’s exit from
the fertilizer business and stake sale in other non-core assets should act as key cash
generators for debt repayment. We expect TTCH’s net debt-equity ratio to reduce
from 0.7x in FY17 to almost nil by FY20. Consequently, interest coverage ratio
should improve from 4.1x in FY17 to 10x in FY20. Adjusted PAT from continuing
operations is likely to grow at 22% CAGR over FY18-20 to INR12.8b. We assume tax
rate of 27% in FY18, and 28% in FY19 and FY20 against 24.7% in FY17. We expect
core RoCE (excluding goodwill, investment and cash) to improve by 534bp to 18% by
FY20 from 12.8% in FY18. We believe TTCH’s performance should be gauged on core
RoCE, as the company is in the process of selling non-core assets and investments –
it will be deploying the high cash on its books in high RoCE businesses. Blended RoCE
is likely to improve by 216bp to ~10% by FY20 from 7.8% in FY18.
Exhibit 83: Revenue to grow at CAGR of 9.3% over FY18-20
Revenue (INR b)
Growth (%)
9.2
9.4
13.7
-13.4
-12.7
-20.4
152
FY16
133
FY17
106
FY18E
116
FY19E
126
FY20E
20.9
FY16
22.2
FY17
22.6
FY18E
24.7
FY19E
27.2
FY20E
16.7
Exhibit 84: EBITDA to expand by 467bp over FY17-18
EBITDA (INR b)
EBITDA Margin (%)
21.4
21.4
21.5
Source: Company, MOSL
Source: Company, MOSL
Exhibit 85: Transformation into a net debt-free company
Net Debt (INR b)
1.1
0.7
0.1
0.1
0.0
Net Debt to Equity Ratio
Exhibit 86: Debt reduction to lower interest expense
Interest Expense (INR b)
Interest Coverage Ratio
10.0
8.2
4.1
5.3
3.0
78.2
FY16
51.9
FY17
12.7
FY18E
9.2
FY19E
3.0
FY20E
5.3
FY16
4.1
FY17
3.3
FY18E
2.4
FY19E
2.1
FY20E
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
41

Tata Chemicals
Exhibit 87: Net worth to grow at ~11% CAGR over FY17-20
Net Worth (INR b)
23.5
18.8
15.4
6.9
68.5
FY16
79.1
FY17
93.9
FY18E
100.4
FY19E
7.4
107.8
FY20E
101
FY16
-48.5
52
FY17
48
FY18E
47
FY19E
45
FY20E
15.9
-7.5
-2.1
-4.3
Growth (%)
Exhibit 88: Improvement in WC cycle
Working Capital Cycle (Days)
Growth (%)
Source: Company, MOSL
Source: Company, MOSL
Exhibit 89: RoCE and RoE to show an improving trend
ROCE (%)
9
14
11
9
11
12
11
Core ROCE
9
13
16
12
ROE
10
18
12
Exhibit 90: Adjusted PAT to grow at 22% CAGR over FY18-20
Adj. PAT Continuing operation (INR b)
9.7
PAT Margin (%)
10.1
8
6.5
4.6
7.0
8.6
FY17
8.1
8.6
FY18E
11.2
FY19E
12.8
FY20E
FY16
FY17
FY18E
FY19E
FY20E
FY16
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
42

Tata Chemicals
Exhibit 91: Key assumptions
Particulars (INR m)
Standalone
Inorganic Chemical-India
Soda Ash India
Volume (in tonnes)
Growth (%)
Realisation (INR per tonne)
Growth (%)
Sodium Bi Carbonate India
Volume (in tonnes)
Growth (%)
Realisation (INR per tonne)
Growth (%)
Others (Inorganic Chemicals+ Cement)
Revenue(INR m)
Growth (%)
EBITDA-Inorganic Chemical-India
EBITDA margin (%)
Consumer (Salt+others)
Revenue(INR m)
Growth (%)
EBITDA(INR m)
EBITDA margin (%)
TCNA
INR/USD
Volume (in tonnes)
Growth (%)
Realisation (USD per tonne)
EBITDA/Tonne(USD)
TCEHL
INR/GBP
Volume (in tonnes) (Soda ash+ Sodium
bicarbonate)
Growth (%)
Realisation (GBP per tonne)
EBITDA/MT(GBP)
TATA Chemicals Africa
Volume (in tonnes)
Growth (%)
Realisation (USD per tonne)
EBITDA/MT(USD)
Rallis India
Revenue(INR m)
Growth (%)
EBITDA
Margin (%)
FY15
FY16
FY17
FY18E
FY19E
FY20E
683266
-1%
21,952.36
12%
88,066.00
2%
21,154.59
11%
2,802
-21%
8,329
26.1%
14974
15%
3,766
25%
61
2362711
-1%
209
51
99
596000
-14%
294
12.6
301686
-38%
369
42
18218
4%
2827
15.5%
685000
0%
23,389.93
7%
89,000.00
1%
22,220.43
5%
5,962
113%
9,519
26.7%
16190
8%
3,613
22%
65
2103566
-11%
219
47
99
592000
2%
290
28.1
307000
2%
347
57
16278
-11%
2290
14.1%
708000
3%
21,882.34
-6%
94,338.00
6%
20,713.75
-7%
4,708
-21%
9,723
28.2%
16037
-1%
3,493
22%
67
2241000
7%
212
43
88
586000
8%
315
45.0
272000
-11%
322
27
17380
7%
2634
15.2%
713664
1%
21,904.23
0%
99,054.90
5%
22,370.85
8%
4,155
-12%
9,804
28.4%
14324
-11%
3,941
28%
64
2308230
3%
215
48
84
544200
-3%
324
46.0
327760
21%
326
50
17901
3%
2739
15.3%
724368.96
2%
22,561.35
3%
1,01,036.00
2%
23,489.39
5%
4,443
7%
10,322
28.4%
16182
13%
4,530
28%
66
2354395
2%
221
49
86
565845
5%
327
47.0
337592.8
3%
333
50
20587
15%
3150
15.3%
7,38,856.34
2%
23,238.19
3%
1,03,056.72
2%
24,194.07
3%
4,733
7%
10,799
28.2%
18318
13%
4,908
27%
68
2401482
2%
228
50
88
593117.7
6%
331
48.0
340968.728
1%
339
51
23675
15%
3859
16.3%
2 April 2018
43

Tata Chemicals
Valuation and view
Initiating with Buy
Strategic transformation of business to drive value upward
TTCH is engaged in the manufacture of soda ash, consumer products and crop
protection. It has taken strategic initiatives to: 1) rapidly grow the consumer
business, including salt, pulses and spices via an expanded product portfolio,
leveraging the Tata brand, strong distribution network of the salt business and
strategic sourcing, 2) expand the portfolio, with the launch of new specialty and
consumer (S&C) products, and 3) divest the regulated fertilizer business. We expect
the share of S&C business to reach 33% by FY20, based on its existing product
portfolio. Also, the launch of new products could act as a catalyst to drive the
contribution higher. The company’s future investments are also clearly directed
toward higher-RoCE businesses (20-25%), such as investment of ~INR3b each in the
highly dispersible silica and nutraceuticals businesses. These products are developed
in-house, and the company plans to launch more products.
We have valued TTCH based on SOTP (refer exhibit 92) and arrived at a target price
of INR940 (implied EV/EBITDA is 9.7x). The stock has traded at a one-year forward
EV/EBITDA of 7.5x (average) for the last five years. Considering the increased
focus/business transformation toward a higher-RoCE segment (specialty &
consumer) and the divestment of a regulated business (fertilizer), we believe it is fair
to assign ~30% premium to its five-year average EV/EBITDA. Net debt as on FY17
stood at ~INR52b. We believe the company should become net-debt-free by FY20
via (i) cash generated from the divestment of the fertilizer business, (ii) sale of
investment in Tata Global Shares, (iii) internal accruals, and (iv) potential sale of
investment in group companies. Average free cash flow yield over FY19-20 is
estimated at ~9%. We initiate coverage on TTCH with a
Buy
rating.
The stock trades at 16x FY19E EPS of INR44 and 13.8x FY20E EPS of INR50.3, and at
8.4x FY19E EBITDA of INR24.7b and 7.4x FY20E EBITDA of INR27.2b. On a P/E and
EV/EBITDA basis, the company has historically traded at a five-year average of 12.5x
and 7.5x, respectively.
2 April 2018
44

Tata Chemicals
Exhibit 92: BUY with an upside of 36% (INR m)
Business
Commodity
Inorganic Chemical India (Soda Ash & others)
(Excluding Salt)
Tata Chemicals North America
Sub Total
Speicalty and Consumer
Consumer (Incl Salt)
Rallis India Ltd (Tata Chemicals hold 50% )
Total EV
Less: Debt FY20
Less: Minority Interest
Add: Cash & Liquid investment
Add: Value of quoted Investment
Target Mcap
Outstanding share (m)
Target Price (INR)
CMP (INR)
Upside (%)
Implied EV
Implied EV/EBITDA (X)
Market Capitalisation
16,843
0.8
EV/EBITDA (x)
EBITDA
4,908
45,603
17
0.8
83,430
18,241
250,246
40,523
26,239
42,586
13,475
239,545
255
940
692
35.8%
263,721
9.7
Source: Company, MOSL
20% discount to Current
Attributable Mcap
MCAP
Methodology
Metrics
FY20
Multiple
(x)
7
10
6
EV/ MCAP
(INR m)
45,118
81,290
22,167
148,575
EV/EBITDA (x)
EV/EBITDA (x)
EBITDA
EBITDA
EBITDA
6,445
8,129
3,694
18,269
Tata Chemicals Europe and Tata Chemicals Africa EV/EBITDA (x)
2 April 2018
45

Tata Chemicals
Exhibit 93: Peer Group comparison
Company Name
Consumer
Dabur India Ltd
Colgate-Palmolive India Ltd
Hindustan Unilever Ltd
ITC Ltd
Britannia Industries Ltd
Zydus Wellness
Pidilite Industries Ltd
Soda Ash
GHCL Ltd
Ciner Resources LP
FMC Corp
0.4
0.6
10.3
7.7
11.1
13.8
7.3
11.2
12.5
6.5
10.9
11.2
6.1
5.8
10.8
5.0
5.8
10.0
4.6
6.3
9.3
22.1
NA
20.3
19.6
NA
17.1
18.5
NA
16.2
8.8
4.4
44.4
47.7
9.2
0.7
7.4
44.3
44.1
58.8
28.9
60.6
38.1
53.3
37.1
37.4
48.3
25.4
48.6
32.0
45.6
32.0
31.2
40.8
22.6
38.8
28.1
39.7
34.5
25.9
40.5
19.0
40.6
36.8
33.7
28.5
22.6
33.4
16.7
32.5
31.3
29.1
24.5
19.2
28.3
14.7
25.9
27.7
25.0
25.4
49.9
76.5
22.8
33.9
20.2
24.2
26.7
55.5
91.4
23.8
35.8
20.3
24.5
28.6
61.9
107.9
24.8
40.1
20.6
24.7
MCap
(USD b)
P/E(x)
FY18E
FY19E
FY20E
FY18E
EV/EBITDA (x)
FY19E
FY20E
FY18E
RoE(%)
FY19E
FY20E
Exhibit 94: 1yr forward P/E
P/E (x)
Min (x)
23.0
18.0
13.0
8.0
3.0
Avg (x)
+1SD
Max (x)
-1SD
Exhibit 95: 1yr forward EV/EBITDA
EV/EBITDA (x)
Max (x)
+1SD
Avg (x)
Min (x)
-1SD
11.0
9.0
19.0
15.0
11.4
7.9
4.5
9.3
15.7
7.0
5.0
3.0
8.1
7.0
6.0
4.0
7.5
Source: Company, MOSL
Source: Company, MOSL
2 April 2018
46

Tata Chemicals
Key risks
New capacity addition from Turkey
New soda ash capacity addition from Turkey would affect the market dynamics.
Turkey’s annual production capacity is expected to increase from 2.9 million tonnes
in 2015 to nearly 5.4 million tonnes by 2018.
Governmental policy risks
There is currently an anti-dumping scheme in place by the Indian government
against imports of soda ash. This is keeping prices stable and is avoiding the
downward pressure on the prices. If this scheme is removed due to other political
factors, there could be an adverse impact on TTCH’s margins.
Operational risks
TTCH is a global organization, and there are a multitude of labor laws,
environmental regulations and other factors for every country that TTCH operates
in. There are operational risks for every country that can have an impact on the
company’s operations.
Foreign exchange risk
TTCH is a global organization that has sales in a number of different countries with a
variety of currencies in play. The company has to hedge and manage risks relating to
currency fluctuations, which could otherwise have a significant impact on the
accounts of the company.
2 April 2018
47

Tata Chemicals
Management overview
R Mukundan, Managing Director and CEO
Mr Mukundan is an Engineer from IIT Roorkee. He joined the Tata Administrative
Service in 1990, after completion of MBA from FMS, Delhi University. He is also an
alumnus of the Havard Business School. During his 26-year career with the Tata
group, he has held various responsibilities across the Chemical, Automotive and
Hospitality sectors. He serves on executive committees of various industry forums –
the Confederation of Indian Industry, Bombay Chamber of Commerce and Industry,
Employers' Federation of India, All India Management Association, etc.
John Mulhall, Chief Financial Officer
Mr Mulhall joined Tata Chemicals in 2007 as the European Finance Director of its
recently acquired subsidiary, Brunner Mond (UK), followed by positions in Tata
Chemicals North America Inc, (VP and CFO) and Tata Chemicals International Pte in
Singapore (CFO). He relocated to Mumbai in 2015. Prior to Tata Chemicals, Mr
Mulhall worked in Finance for various UK manufacturing companies. He is a
graduate of the University of Strathclyde and a member of the Institute of Chartered
Accountants of Scotland.
Rackanchath Nanda, Chief Human Resources Officer
Mr Nanda started his career with the Murugappa Group in Chennai, where he spent
nearly 15 years in a variety of roles – in Human Resources and also as the Head of
Manufacturing and Commercial functions for the foods business. He has also led the
Human Resource function for Amara Raja Group and the Dubai-based Landmark
Group. Mr Nanda joined the Tata group in 2006 with his first role being at Tata
Communications. He moved to Tata Chemicals in May 2012 and currently oversees
the global functions of Human Resources. Mr Nanda has completed his post-
graduation in human resources and has also done several professional certifications
and executive development programs.
Rajiv Chandan, General Counsel & Company Secretary
Mr Chandan heads the Legal, Company Secretarial and Corporate Governance
functions at Tata Chemicals. His experience is spread across diverse industries,
including the Paper, Automobiles, Logistics, Cement, Chemicals, FMCG and Fertilizer
sectors. Before joining Tata Chemicals, he was Vice President – Legal and Company
Secretary, Lafarge Cement, India. Mr Chandan is a fellow member of the Institute of
Company Secretaries of India, and has a Masters' degree in Commerce and a Law
degree from the University of Mumbai.
2 April 2018
48

Tata Chemicals
Financials and valuations
Consolidated - Income Statement
Y/E March
Total Income from Operations
Change (%)
Total Expenditure
% of Sales
EBITDA
Margin (%)
Depreciation
EBIT
Int. and Finance Charges
Other Income
PBT bef. EO Exp.
EO Items
PBT after EO Exp.
Total Tax
Tax Rate (%)
Minority Interest
Reported PAT - Continuing Ops.
Adjusted PAT - Continuing Ops.
Change (%)
Margin (%)
Reported PAT - Discontinuing Ops.
Reported PAT
Adjusted PAT
FY13
150,343
7.0
128,715
85.6
21,628
14.4
5,339
16,289
4,639
4,178
15,828
-6,699
9,129
3,025
33.1
2,100
4,004
8,483
-10.9
5.6
0
4,004
8,483
FY14
162,274
7.9
144,178
88.8
18,096
11.2
4,712
13,384
5,795
1,424
9,013
-14,202
-5,189
2,888
-55.7
2,243
-10,320
11,786
38.9
7.3
0
-10,320
11,786
FY15
175,708
8.3
154,065
87.7
21,643
12.3
4,631
17,012
4,609
1,180
13,582
-1,997
11,585
3,511
30.3
2,109
5,965
7,356
-37.6
4.2
0
5,965
7,356
FY16
152,202
-13.4
131,285
86.3
20,917
13.7
5,261
15,657
5,255
1,253
11,655
0
11,655
2,484
21.3
2,207
6,964
6,964
-5.3
4.6
742
7,706
7,706
FY17
132,889
-12.7
110,653
83.3
22,237
16.7
5,347
16,889
4,112
1,661
14,439
0
14,439
3,573
24.7
2,282
8,583
8,583
23.3
6.5
1,348
9,931
9,931
FY18E
105,804
-20.4
83,162
78.6
22,642
21.4
5,258
17,384
3,303
1,058
15,139
14,255
29,395
7,937
27.0
2,465
18,993
8,587
0.0
8.1
1,217
20,210
9,803
FY19E
115,508
9.2
90,789
78.6
24,719
21.4
5,413
19,306
2,358
2,310
19,258
0
19,258
5,392
28.0
2,662
11,203
11,203
30.5
9.7
0
11,203
11,203
(INR Million)
FY20E
126,324
9.4
99,164
78.5
27,160
21.5
5,771
21,388
2,136
2,526
21,779
0
21,779
6,098
28.0
2,875
12,805
12,805
14.3
10.1
0
12,805
12,805
Consolidated - Balance Sheet
Y/E March
Equity Share Capital
Total Reserves
Net Worth
Minority Interest
Total Loans
Deferred Tax Liabilities
Capital Employed
Gross Block
Less: Accum. Deprn.
Net Fixed Assets
Goodwill on Consolidation
Capital WIP
Current Investments
Total Investments
Curr. Assets, Loans&Adv.
Inventory
Account Receivables
Cash and Bank Balance
Loans and Advances
Curr. Liability & Prov.
Account Payables
Other Current Liabilities
Provisions
Net Current Assets
Appl. of Funds
FY13
2,548
61,587
64,136
5,361
83,840
-56
153,281
106,053
65,282
40,771
66,287
5,916
13
5,997
81,830
16,018
34,401
18,414
12,997
47,519
15,572
14,753
17,194
34,311
153,281
FY14
2,548
53,107
55,655
6,552
83,931
1,910
148,048
112,504
69,677
42,827
67,243
4,676
67
4,409
81,705
16,490
32,409
17,530
15,276
52,812
13,992
17,080
21,740
28,893
148,048
FY15
2,548
52,969
55,517
6,735
83,788
2,062
148,102
120,084
76,081
44,003
69,586
1,893
55
4,429
88,109
26,264
34,267
14,643
12,936
59,918
18,891
16,341
24,686
28,191
148,102
FY16
2,548
65,995
68,543
25,985
90,904
12,348
197,780
120,671
5,490
115,181
17,619
5,015
94
21,879
83,769
19,319
35,656
12,654
16,140
45,682
16,818
7,923
20,941
38,086
197,780
FY17
2,548
76,534
79,082
26,239
70,719
12,144
188,184
117,703
9,839
107,864
16,984
4,791
2,205
27,907
78,269
13,809
20,884
16,654
26,923
47,630
14,427
11,462
21,741
30,639
188,184
FY18E
2,548
91,398
93,946
26,239
49,394
12,144
181,724
116,672
15,097
101,575
16,984
4,958
2,205
21,407
69,991
10,004
15,943
34,522
9,522
33,192
10,592
5,290
17,310
36,799
181,724
FY19E
2,548
97,883
100,431
26,239
44,928
12,144
183,742
124,639
20,510
104,129
16,984
4,992
2,205
21,407
72,467
10,921
17,089
38,682
5,775
36,236
11,563
5,775
18,898
36,231
183,742
(INR Million)
FY20E
2,548
105,294
107,843
26,239
40,523
12,144
186,749
132,632
26,281
106,351
16,984
4,998
2,205
21,407
76,638
11,944
17,997
40,381
6,316
39,630
12,646
6,316
20,667
37,008
186,749
2 April 2018
49

Tata Chemicals
Financials and valuations
Ratios
Y/E March
Basic (INR)
EPS
Cash EPS
BV/Share
DPS
Payout (%)
Valuation (x)
P/E
Cash P/E
P/BV
EV/Sales
EV/EBITDA
Dividend Yield (%)
FCF per share
Return Ratios (%)
RoE
RoCE
Core RoCE
RoIC
Working Capital Ratios
Fixed Asset Turnover (x)
Asset Turnover (x)
Inventory (Days)
Debtor (Days)
Creditor (Days)
Leverage Ratio (x)
Current Ratio
Interest Cover Ratio
Net Debt/Equity
FY13
33.3
54.2
251.7
10.0
75.7
FY14
46.3
64.7
218.4
10.0
-29.0
FY15
28.9
47.0
217.9
12.5
65.7
24.0
14.7
3.2
1.4
11.7
1.8
27.8
13.2
9.1
22.2
9.5
1.5
1.2
137
71
99
1.5
3.7
1.2
FY16
27.3
48.0
269.0
10.0
45.0
25.3
14.4
2.6
1.8
13.4
1.4
64.6
11.2
8.9
14.0
8.6
1.3
0.8
119
86
103
1.8
3.0
1.1
FY17
33.7
54.7
310.3
11.0
40.2
20.5
12.7
2.2
1.9
11.4
1.6
113.3
11.6
9.0
11.3
8.6
1.1
0.7
122
57
127
1.6
4.1
0.7
FY18E
33.7
54.3
368.7
13.8
21.7
20.5
12.7
1.9
2.0
9.5
2.0
163.0
11.3
7.8
12.8
9.8
0.9
0.6
119
55
126
2.1
5.3
0.13
FY19E
44.0
65.2
394.1
15.8
42.1
15.7
10.6
1.8
1.8
8.4
2.3
63.0
11.5
9.1
16.3
11.6
0.9
0.6
119
54
126
2.0
8.2
0.04
FY20E
50.3
72.9
423.2
18.1
42.1
13.8
9.5
1.6
1.6
7.4
2.6
54.9
12.3
9.9
18.1
12.9
1.0
0.7
119
52
126
1.9
10.0
-0.02
1.4
-14.3
13.3
9.7
23.9
9.4
1.4
1.0
101
84
98
1.7
3.5
1.0
1.4
68.4
19.7
16.0
38.5
17.0
1.4
1.1
96
73
82
1.5
2.3
1.2
Consolidated - Cash Flow Statement
Y/E March
OP/(Loss) before Tax
Depreciation
Interest & Finance Charges
Direct Taxes Paid
(Inc)/Dec in WC
CF from Operations
Others
CF from Operating incl EO
(Inc)/Dec in FA
Free Cash Flow
(Pur)/Sale of Investments
Others
CF from Investments
Inc/(Dec) in Debt
Interest Paid
Dividend Paid
Others
CF from Fin. Activity
Inc/Dec of Cash
Opening Balance
Closing Balance
FY13
9,130
5,339
4,468
-3,584
-17,107
-1,755
3,965
2,210
-5,842
-3,632
201
3,772
-1,869
8,966
-4,641
-3,033
0
1,292
1,633
16,780
18,414
FY14
-5,189
4,712
5,133
-2,307
3,795
6,144
17,232
23,376
-5,938
17,438
-59
390
-5,607
-9,894
-5,798
-2,961
0
-18,653
-883
18,414
17,530
FY15
11,585
4,631
4,241
-3,612
-11,245
5,600
7,136
12,736
-5,649
7,087
-29
928
-4,750
-3,417
-4,430
-3,026
0
-10,873
-2,887
17,530
14,643
FY16
12,935
5,714
5,946
-3,645
-652
20,298
3,022
23,319
-6,865
16,454
-90
-337
-7,292
-6,098
-6,202
-3,820
-1,897
-18,017
-1,989
14,643
12,654
FY17
16,522
5,522
4,645
-4,516
12,103
34,276
1,033
35,309
-6,429
28,880
-2,064
588
-7,905
-14,117
-4,456
-3,056
-1,776
-23,404
4,000
12,654
16,654
FY18E
15,139
5,258
2,245
-7,937
11,708
26,414
14,255
40,669
863
41,532
6,500
1,058
8,421
-21,324
-3,303
-4,129
-2,465
-31,221
17,869
16,654
34,522
FY19E
19,258
5,413
48
-5,392
4,728
24,055
0
24,055
-8,000
16,055
0
2,310
-5,690
-4,466
-2,358
-4,719
-2,662
-14,205
4,159
34,522
38,682
FY20E
21,779
5,771
-390
-6,098
922
21,983
0
21,983
-8,000
13,983
0
2,526
-5,474
-4,405
-2,136
-5,394
-2,875
-14,810
1,700
38,682
40,381
(INR
2 April 2018
50

REPORT GALLERY
RECENT INITIATING COVERAGE REPORTS
.
Rs

Explanation of Investment Rating
Investment Rating
BUY
SELL
NEUTRAL
UNDER REVIEW
NOT RATED
Expected return (over 12-month)
>=15%
< - 10%
> - 10 % to 15%
Rating may undergo a change
We have forward looking estimates for the stock but we refrain from assigning recommendation
Tata Chemicals
*In case the recommendation given by the Research Analyst becomes inconsistent with the investment rating legend, the Research Analyst shall within 28 days of the inconsistency, take appropriate measures to make the recommendation consistent with the investment rating legend.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of
which are available on
www.motilaloswal.com.
MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited
(BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of
Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at
http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI:
SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per SEBI regulations to hold inquiry and
adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred in Show Cause Notice. The matter is closed and MOSL had to pay Rs. 2
lakhs towards penalty for misplacement of original POA of client.
MOSL, it’s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at
the end of the month immediately preceding the date of publication of the Research Report.
MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act
as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.;
however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there
might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have
received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a)
managed or co-managed public offering of securities from subject company of this research report,
b)
received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c)
received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d)
Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in
this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result,
the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part
or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report
is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied,
is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to
buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by
virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the
specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Analyst ownership of the stock
Tata Chemicals
No
A graph of daily closing prices of securities is available at
www.nseindia.com, www.bseindia.com.
Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or
its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have
expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject
MOSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong)
Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to “Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only
available to professional investor and will be engaged only with professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from
registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered
investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption
under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional
Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional
investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule
15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S.,
MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of
this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject
to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal
Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the
Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced
in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial
instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in
this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of
independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including
those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy,
completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the
views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval.
MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform
investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this
into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and
the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or
published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall
be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information.
The person accessing this information specifically agrees
to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL
or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm
Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id:
na@motilaloswal.com,
Contact No.:022-30801085.
Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MSE); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100.
Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth
management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real
Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products
2 April 2018
52